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Ventricular fibrillation is the most common cause of cardiac
arrest in patients with atherosclerotic coronary artery dis-
ease (1). Electrical cardioversion of ventricular fibrillation is
frequently followed by a postcountershock pulseless rhythm
(secondary electromechanical dissociation) or ventricular
asystole (2,3). Despite a gradual improvement in outcome of
cardiopulmonary resuscitation in cardiac arrest victims out
of hospital over the past decades, bradycardic and asystolic
arrests continue to carry a very grave prognosis (4). Phar-
macologic interventions, including high dose epinephrine
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(5-8), and nonpharmacologic procedures, including percuta-
neous pacing, have not been shown to have a significant
impact on outcome (9,10) .
Endogenous adenosine, which accumulates during by-
poxia and ischemia (11), is a potent mediator of bradyar-
rhythmias (12). Adenosine has been shown to depress sino-
atrial node activity, atrioventricular (AV) node conduction,
atrial contractility and ventricular automaticity (13). It can
also attenuate the stimulatory, actions of calecholamincs (14)
and the release of norepinephrine by adrenergic nerve stim-
ulation (15). In ventricular muscle, adenosine exerts a potent
indirect negative inotropic effect if the tissue is stimulated by
atecholamines and the adenylyl cyclase system is activated
(16). Although all of these electrophysiologic and hemody-
namic effects of adenosine may serve as a protective mech-
anism in myocardial ischenda (17), they may also contribute
to the postcountershock asystoe and electromechanical
dissociation observed frequently after cardioversion from
prolonged ventricular fibrillation (18) . Indeed, recent studies
have shown that selective A, adenosine receptor antagonists
0733.1097Aes7.00
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can enhance postdefibrillation contractility in experimental during resuscitation . The micromanometer-tipped catheters
animals (18,19). were calibrated to atmospheric pressure with the use of a
Theophylline is a nonspecific adenosine receptor antago- Control Unit (Millar Instruments, Inc .). 5) A 6F quadripolar
nist (20) that has been shown in anecdotal cases to reverse electrode catheter was advanced to the right ventricular
the atropine-resistant complete AV block observed in acute apex for induction of ventricular fibrillation ; and 6) a 6F
inferior myocardial infarction (21) and to increase the sinus straight lumen catheter was advanced to the abdominal aorta
rate in certain patients with the sick sinus syndrome or for blood sampling,
vasodepressor syncope (22,23) . A recent uncontrolled clini- Three surface electrocardiographic (ECG) leads and the
cal study has indicated that a rapid intravenous bolus of
right atrial and aortic root pressures were continuously
aminophylline might improve the immediate outcome in monitored and recorded throughout the experiments . Base-
bradyasystolic cardiac arrest that had been refractory to line measurements included :hermodilution cardiac ouiput
atropine and epinephrine (24)
.
In preparation of a prospec- (mean of three measurements), systolic, diastolic, mean
tive clinical trial, the present experiments : study was under- aortic and right atria) pressures ; partial pressure of arterial
taken to establish in a controlled, systematic fashion the oxygen (Pao,), Paco, and arterial pH ; and serum potassium,
beneficial effects of aminophyllinc in the prevention or ionized calcium, glucose and lactase levels . During cardiac
reversal of electromechanical dissociation in a canine mode! arre ;t acd resuscitation, the following variables were mea-
of cardioversion from prolonged, unsupported ventricular sured at 5-min intervals : peak systolic aortic
and right atria)
fibrillation . Unexpectedly, aminophylline turned
out to have pressures (compression phase of external cardiac massage) ;
no positive impact on the outcome of cardiopulmonary diastolic aortic and right atria) pressures (relaxation phase of
resuscitation . cardiac massage) ; coronary perfusion pressure (aortic and
right atrial pressure difference)
; Pao,, Paco, and arterial pH ;
and end-tidal carbon dioxide. Serum chemistry measure-
Methods
ments were repeated at 30 min after defibrillation and at
The study was approved by the Research Review Com- 60 sin in survivors . Thermodilution cardiac output was
mittee and the Institutional Animal Care and Use Committee estimated at 60 min in survivors. Serum theophylline levels
at the Carolinas Medical Center. All interventions performed were drawn at 10 min after injection of the
"study drug"
in this study conformed with the "Position of the American (aminophylline or normal saline solution)
for retrospective
Heart Association on Research Animal Use" adopted by the
verification of the agent used . All serum chemistry measure-
Association in November 1984. ments were performed by routine laboratory techniques .
Ana. Forty healthy male and female adult mongrel Cardiopulmonary arrest and resuscitation . Cardiopulmo-
dogs weighing IS to 32 kg were fasted overnight but allowed nary arrest was started by disconnecting the respirator
from
access to water. Anesthesia was induced with sodium thio- the endotracheal tube
. Ventricular fibrillation was simply
penal, 10 to 20 mg intravenously . After orotracheal
intuba- induced by a 3- to 5-s application of direct current from a
Lion, anesthesia was maintained with isoflurane,
1 .0% to commercial 9-V battery through the right ventricular endo-
2
.0% . Mechanical ventilation was performed with a Harvard cardial electrode (25)
. Ventricular fibrillation was confirmed
respirator ; minute ventilation was adjusted to maintain arte- in three ECG leads and by the characteristic decline
in aortic
Dial pH 7.35 to 7.45 and partial pressure of arterial carbon pressures
. During the arrest period, gas exchange and circu-
dioxide (Paco2) of 30 to 40 mm Hg . During instrumentation
lation remained unsupported .
and the control period, the fraction of inspired
oxygen was Resuscitation included positive-pressure
ventilation, ex-
maintained at 0 .21 . Animals were kept on a heating blanket,
ternal cardiac massage and direct current transthoracic
and room temperature was also adjusted to avoid hypother-
electrical cardioversion, where applicable . Positive-pressure
mia. Core body temperature measured through a pulmonary
ventilation was performed by an Arrbu bag at 12 to 14
artery catheter did not decrease <37°C . Cardiac arrest was
breaths/min using a supplemental oxygen flow rate of 15
always induced > 1 h after the initial low dose thiopental
liters/min. Once a stable circulatory state was attained, the
administration .
endotracheal tube was reconnected to the Harvard respira-
Inatrumearallon and monitoring. A total of six catheters for, allowing reinstitution of isollurane, and thereafter the
were introduced into each dog with a percutaneous tech-
fraction of inspired oxygen was kept at 1.0 . Closed-chest
nique through femoral arteries and veins and were
advanced cardiac massage was performed by placing the dog in
the left
to the respective cardiac chambers under fluoroscopic
guid- decubitus position and manually compressing the
thorax at a
ance: 1) a 7.SF thernlodilution catheter
to a branch of the rate of 100 to I101min . A compression/relaxalion
ratio of
pulmonary artery for the estimation of cardiac output
and to -1 :1 and an 8 :1 compression/ventilation
ratio were used.
monitor core temperature
; 2) a 7F multipurpose catheter to
Compression strength was adjusted in an attempt to maintain
the right atrium for drug delivery ; 3) a 7F micromanometer-
a peak aortic pressure >60 mm Hg . Transthomcic electrical
tipped catheter to the right atrium; and 4) a 7F microman-
cardioversion was performed by a commercial direct
current
ometer-tipped catheter to the aortic root
. These last two external defibrillator
. The sequence of delivered counter-
catheters served to estimate coronary
perfusion pressures shock energies was 100, 200 and 400 J




AMINOPHYLLINE IN CARDIOPULMONARY RESUSCITATION
lion was immediately or subsequently required, it was
performed at 4101. Sequential countershocks were admin-
istered as soon as the defibrillator was recharged to a
maximum of 10 times. If 10 sequential countershocks failed
to convert ventricular fibrillation, the experiment was termi-
nated
.
Pharmacologic agents. In addition to low rate heparinized
normal saline solution drip through the lumen catheters,
each dog receiver' a continuous infusion of 0.9% sodium
chloride at 15 mlllmin throughout the experiments . As part of
the resuscitation protocol, each dog received I teg of epi-
nephrine diluted to 10 ml in 0 .9% sodium chloride as a rapid
bolus into the right atrium, followed by a normal saline
solution flush, before or after cardioversion (see later)
. The
"study drug" was 250 mg of aminophyiline in 10-ml vials or
10 ml of 0.9% NaCl in identical vials. All vials were labeled
"study drug" and were coded by numbers . Assignment of
aminophylline and sodium chloride to individual code num-
bers was according to a computer-generated random number
table
. Each investigator was unaware of the actual agent
given ; the code was broken after completion of the experi-
ments, The "study drug" was injected into the right atrium
as a rapid bolus followed by a normal saline solut an flush at
a predetermined stage of cardiopulmonary resuscitation (see
later) . The experimental animals did not receive further
phatmacologic support in addition to epinephrine, amino-
phylline and normal saline solution .
EJpsdmental protocols . Protocol I (n = 20) : study drug
during ventricular fibrillation . The respirator was turned
off, and ventricular fibrillation was induced ; all respiratory
or circa' -'ory support was withheld
. At 6
.5 min into ventric-
ular fibrillation, bagging with supplemental oxygen was
started . One milligram of epinephrine was injected into the
right atrium, followed by 15 s of cardiac massage . Then the
"study drug" (aminophylline or normal saline solution) was
injected into the right atrium followed by cardiac massage
.
At 7.5 min into ventricular fibrillation (I min after epineph-
rine injection), one or more transthoracic countershocks
were performed in succession, as described earlier, until
ventricular fibrillation was terminated, a maximum of 10
times .
Protocol 2 (n = 20) : study drug during electromechanical
dissociation. The respirator was turned off, and ventricular
fibrillation was induced ; all respiratory and circulatory sup-
por, was withheld. At 5 min into ventricular fibrillation,
bagging with supplemental oxygen was started, and sequen-
tial transthoracic countershocks were delivered without pre-
vious pharmacologic interventions or cardiac massage . All
dogs were successfully cardioverted to asyst :le followed by
electromechanical dissociation . Cardiac massage was
started at 30 s into asystole or electromechanical dissocia-
tion . Epinephrine and the "study drug" were injected into
the right atrium at 60 s and 90 s after successful cardiover-
sion, respectively.
In both experiments, cardiopulmonary resuscitation was
continued until
an effective heart rate >60 beats/min and a
Table 1. Survival in Protocols I and 2
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Data premed are 95% confidence imervais 195% CD or number of dogs.
spontaneous systolic blood pressure >60 mm Hg were
observed, up to 30 min. If resuscitation efforts were unsuc-
cessful at 30 min, hemodynamic variables were measured,
blood chemistry were measured, and the experiment was
terminated . If resuscitation was successful, the dogs were
followed up for I h without further interventions except for
intermittent cardiac massage and ventilation, if necessary .
StaWUadanalysis. The primary end point was survival to
I h . Secondary end points were the number of counter-
shocks used to terminate v,:mricular fibrillation (in protocol
1), coronary perfusion pressures during resuscitation in
survivors versus nonsurvivors and change in cardiac output
from prearrest to end of experiment in survivors .
The number of animals in each protocol was based on the
following considerations. Assuming a survival rate of S0% in
the placebo group, it would have required 57 dogs per group,
114 dogs per protocol, to show a 25% increase in survival
(from 50% to 75%) because of aminophylline at a power of
80% and an alpha level of 0.05. These numbers would have
been unacceptable for an initial study . Instead, we chose to
proceed with a convenient number of 20 experiments per
protocol (10 animals per group) and estimated the likelihood
of a beneficial effect on outcome from aminophylline by
approximate 95% confidence intervals of the differences in
survival percents .
The primary end point (overall survival) was analyzed by
the Fisher exact test and by calculating 95% confidence
intervals as described earlier, The Wilcoxon rank-sum test
was used to compare the number of cardioversions required
for defibrillation in each group . Continuous variables in
groups were expressed as mean values ± SD and were
compared by using the Student t test. In all tests, p < 0 .05
was considered statistically significant .
Results
The main results of this experimental study are summa-
rized in Table 1 .
Protocol 1 . Only 4 of 10 dogs survived to I h in the
aminophylline group, whereas 7 of 10 dogs survived in the
placebo group (not significant); 95% confidence intervals for
favorable outcome with aminophylline ranged from -0 .716
to +0.116. This suggests a trend toward a decreased likeli-
hood of survival if dogs received aminophylline . In the
aminophylline group, four dogs could not be cardioverted
with 10 consecutive countershocks; two dogs never survived
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Cable 2. Mean Results of Study Variables During Cardiopulmonary Resuscitation in Survivors Versus Nonsurvivors in Protocols I and 2
Protocol I
Amino (n = 101
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Diass CPP (mm H8)t
'Panmaeed unnlediaeely after cardioversion
in both groups. t Measured within 2 m 'min after cardioversion. All variables arc expressed as mean vmaes ±
SD. Amino = amhwphylline : Ao Stout ~ peak soon pressure during the compression phase of cardiac mass ge ; Just CPP = coronary perfusion pressure
estimated as the aortic-right aerial pressure difference during the relaxation phase of cardiac massage
: N = nonsurvivors : Paco, = partial pressure of arterial
carbon dioxide : Pea = partial pressure of arterial oxygen ; Placebo - saline solution
; S = survivors .
lion. In the placebo group, only one dog could not be
cardiovened with 10 countershccks
; two dogs did net sur-
vive electromechanical dissociation. The total number of
countershocks delivered was larger, but not statistically
significant, in the aminophylline than in the placebo group
(6
.2 ± 3.3 vs. 3 .8 ± 2 .3 per experiment, respectively, p =
0 .14). In survivors, the sequence of hemodynamic events
was similar in both groups : Perfusing rhythm returned 2 to
4 min after effective cardioversion ; this was followed by a
hemodynamically unstable period lasting for 2 to 5 min, with
eventual return of a stable perfusing rhythm.
Protocol 2 . Five of 10 dogs survived to I h in the
aminophylline group and 6 of 10 dogs in the placebo group ;
95% confidence intervals for favorable outcome with amino-
phylline ranged from -0.534 to +0 .334. Here, electrocardio-
version was performed at 5 min into ventricular fibrillation .
without previous cardiopulmonary resuscitation or phanna-
cologic interventions .
In all 20 dogs, a mean of 1 .9 ± 0 .8
cardioversions per experiment were required. Cardioversion
was successful in each experiment : each dog came out of
ventricular fibrillation with asystole followed by electrome-
chanical dissociation
. Epinephrine and the "study drug"
were given at this point, as described in Methods. In the
aminophylline group, one dog died of uncontrollable recur-
rent ventricular fibrillation starting 4 min after an initially
successful cardioversion ; the other four nonsurvivors died of
persistent electromechanical dissociation. All four nonsurvi-
vors in the placebo group died of persistent electromechan-
ical dissociation
. In all survivors, the hemodynamic se-
quence of events was quite similar: asystole for 35 to 110 s.
then a pulseless rhythm for 35 to 144 s, followed by a
perfusing rhythm. In almost each experiment, ventricular
fibrillation recurred within 5 min into electromechanical
dissociation
. The incidence of ventricular fibrillation did not
differ between the two groups: It was present in four of five
and five of six survivors in the aminophylline and control
groups, respectively. Secondary ventricular fibrillation was
successfully cardioverted to an immediately perfusing
rhythm in all. In almost every case, dogs came out of the
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Protocol 2
Amino In = 10) Placebo (n = 10)
initial pulseless rhythm with significant systemic hyperten-
sion, with both systolic and diastolic blood pressures mea-
suring way above those observed during the control period .
At 5 min after cardioversion, systolic blood pressures in
survivors measured 215 ± 89 and 186 ± 70 mm Hg in the
aminophylline and placebo groups, respectively (p = NS for
difference between the two groups). In both groups, initial
hypertension was followed by a gradual decline in blood
pressure and a hemodynamically unstable period lasting for
-5 min, with eventual spontaneous return of a stable per-
fusing rhythm
: thereafter, the rest of the 1-h observation
period was uneventful . There was a dramatic difference in
the course of events between survivors and nonsurvivors :
All animals that developed a perfusing rhythm initially
survived to I h
. whereas if a perfusing rhythm was not seen
within 10 min after cardioversion, continued resuscitation
was unsuccessful without exception. The responders and
nonrespouders, however, did not fall into a particular phar-
macologic -,,roup (aminophylliae or placebo), but both types
of responses were nearly equally distributed within each
group.
Protocols I and 2
. Blood chemistry measurements (in-
cluding arterial blood gases) immediately after cardioversion
and aortic, right atria) and coronary perfusion pressures
during the compression and relaxation phases of external
cardiac massage did not predict outcome (Table 2) . Cardiac
output in survivors decreased from 2 .79'_ 1 .00liters/min at
baseline to 2.33 ± 0 .75 liters/min at I h (not significant) ; the
trend was similar in the aminophylline and placebo groups .
Discussion
Theoretic considerations and a large body of experimen-
tal data suggest that excessive production of endogenous
adenosine may play a significant role in inducing drug-
refractory bradycardia, asystole and electromechanical dis-
sociation after cardioversion from prolonged ventricular
fibrillation (11-19) . It therefore seemed reasonable to assume
that adenosine antagonists might improve the outcome of
S N S N S N S N
128 - 76 188 ! 62 146 5 se 158 x 72 IM, x 48 146 _ 82 140 s 70 168 x 60
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cardiopulmonary resuscitation (18,19,24) . The results of our
placebo-controlled, randomized, blinded experimental
study, however, suggest that postdefibrillation electrophys-
iologic and hemodynamic depression cannot be simply pre-
vented or reversed by direct intracardiac application of the
clinically available adenosine antagonist aminophylline .
Study design . Our experimental protocols were designed
first to use an established experimental model of secondary
asystole or electromechanical dissociation afierdefibrilation
from prolonged ventricular fibrillation and, second, to min-
imize the number of confounding factors by using standard-
ized treatment protocols (26) and by having all investigators
unaware of the study drug used. In protocol 1, a 7 .5-min
ventricular fibrillation time, precardioversion application of
epinephrine and closed chest cardiac massage were based on
a recent experimental study by Niemann et al . (27) ; a
ventricular fibrillation duration of 7 to 8 min seems also to
replicate the clinical cardiac arrest situation out of hospital.
The survival rate in the placebo group turned out to be quite
similar to that of the cor-esponding group in the Niemann et
al . (27) stuiy . In protocol 2, where no epinephrine or cardiac
massage wr4 used before cardioversion, ventricular fibrilla-
tion time was chm , io yield a stable postcountershock
pulseless activity model, as based on numerous experimen-
tal studies (3,5,6,28-32) . Epinephrine was given to each dog
because this would be the first obligatory step in an ad-
vanced cardiac life support protocol (26). Both experimental
protocols were quite useful for the purpose of this study . In
a sense, they represented a cardiopulmonary arrest model
close to a "lethal dose 50" : In protocols I and 2, 70% and
60% of those dogs receiving placebo survived, respectively .
Epinephrine and aminophylline dosages were not adjusted to
body weight . The amount of epinephrine administered was
chosen to represent a high conservative dosage ; aminophyl.
line dosing was designed to achieve an effective theophylline
dose
of 7 to 8 mg/kg body weight in a dog of average body
weight (33,34). Because body weights were not different
between survivors and nonsurvivors, a fixed dosing of
epinephrine and aminophylline probably had no confounding
effect on the outcome .
Analysis of results. In protocol 1, the unfavorable effect
of aminophylline on survival was not completely unex-
pected . This protocol was designed to investigate whether
pretreatment with aminophylline before cardioversion could
present postcardioversion asystole orelectromechanical dis-
sociation. It did not ; in addition, aminophylline administra-
tion was associated with a high incidence of inability to
convert ventricular fibrillation with up to 10 sequential
countershocks. Experimental studies indicate that adenosine
may increase the transthomcic defibrillation threshold (35) .
Other clinical and experimental studies, however, have
demonstrated a proarrhythmic effect of the adenosine antag-
onist aminophylline, manifested in part by a significant
reduction in the ventricular fibrillation threshed (36-38) . It
is possible that combined use of the beta-agosist epinephrine
with aminophylline was responsible for the frequent occur-
rence of persistent ventricular fibrillation (39-41) .
Protocol 2 was a pure postcardioversion nonperfusing
rhythm model. With epinephrine given at 60 s into electro-
mechanical dissociation, followed by cardiac massage, 60%
of the dogs regained a pedusing rhythm and survived to I h .
Additional administration of aminophylline did not further
improve the outcome: Only 50% of dogs in the aminophyl-
line group survived. This observation is at odds with recent
experimental studies that have shown that adenosine recep-
tor antagonism can markedly enhance postdefibrillation con-
tractility when a more specific, more potent (but clinically
unavailable) adenosine receptor antagonist is used (18,19) .
The inability of aminophylline to reverse postdefibrillation
cardiac depression could have been related to a number of
factors, including the following : First, theophylliese is a
weak, nonspecific competitive antagonist of the adenosine
receptor (20,42,43) ; second, blockade of adenosine receptors
may aggravate vasoconstriction of small coronary vessels
elicited by alpha-adrenergic stimulation and thereby de-
crease myocardial perfusion during resuscitation (44); third,
aminophylline might be unable to reverse the electrophysi-
ologic effects of adenosine in the presence of sympathetic
stimulation (45)
;
and fourth, metabolic stimulation of the
heart by epinephrine in the presence of an adenosine recep-
tor antagonist may cause further release of interstitial aden-
osine that can overcome the blockade by rapidly displacing
theophylline from the adenosine receptors and thus way
actually increase cardiac depression (46,47) . Using a more
avid, more potent adenosine receptor antagonist or using an
adenosine receptor antagonist without concomitant cate-
chdarnine stimulation might carry a better chance for the
reversal of postdefibrillation cardiac depression compared
with epinephrine plus aminophylline or placebo (19).
SIMy Yatkatlor. To avoid introduction of a large num-
ber of confounding factors, pharm acologic interventions
were strictly limited to epinephrine in all dogs, followed by
aminophylline or placebo. Thus, not all cardiac medications
allowed or recommended by current advanced cardiac life
support guidelines were used (26) . The results of this study,
therefore, cannot be directly translated to the clinical situa-
tion. We believe, however, that the advantages of keeping
the study "clean" outweighed the disadvantages of pharma-
cologic restriction because, except for the repeated use of
epinephrine, all other pharmacologic interventions are of
questionable benefit in reversing postdefibrglation pulseless
rhythms . The study was also limited by the range of epineph-
rine dosages (including absence of a "no epinephrine"
group) as well as restricting aminophyllne to one single dose
and the speed and route of application . In view of the low
flow state characteristic of cardiopulmonary resuscitation, it
is also possible that, in protocol i, defibrillation was first
attempted before the effects of aminophylline were fully
manifested. The limitations with regard to sample size were
discussed earlier. For an alpha level of 0 .05, a difference in
JACC Vol . 23, No .7
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survival (in favor of placebo) of 30% versus 60%, 10 animals
in each group, had a power of 12%
.
Clinical Implications. The results of this study do not
support the use of aminophylline during any portion of
cardiopulmonary resuscitation . If given during ventricular
fibrillation, aminophylline may even lessen the chances of
successful defibrillation . If it is administered for postcardio-
version asystole or pulseless electrical activity, there is a
lack of demonstrable beneficial effect of conventional doses
of aminophylline when studied in a prospective, controlled,
blinded fashion. In addition, the effect of aminophylline
administration on the success of defibrillation for recurrent
ventricular fibrillation remains uncertain and could be detri-
mental . On the basis of the results of our experimental study,
the rationale of conducting human trials with aminophylline
concomitant with epinephrine during cardiopulmonary re-
suscitation remains questionable.
We acknowledge the expert scientific, technical and administrative assistance
of Mkhnte Thompson . Kathy R . Deem, Elena Leonova, Daryl McCollum .
Edward Freniee. Bob Rittase and Keyna C . Winkler .
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